http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4111994-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 |
| filingDate | 2005-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-4111994-B1 |
| titleOfInvention | Macrolides |
| abstract | As shown below and as defined herein, the macrolide compound itself and its use, eg, as an antibacterial and antiprotozoal agent in animals, including humans: Formula (I). Further disclosed are methods for preparing the compounds of the invention, intermediates and pharmaceutical compositions thereof, and methods for treating or preventing diseases by administering the compounds of the invention to patients in need. This summary is an overview and is not intended to limit the invention. |
| priorityDate | 2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 442.